Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Our clinical team can help you navigate insurance coverage to find an affordable path forward
The cumulative amount of tirzepatide detected in the remaining 7 breast milk samples over the 28-day sampling window was equivalent to less than 0.02% of the maternal administered dose, with the last measurable concentrations occurring 5 days post-dose
While mild nausea is common and generally manageable, certain symptoms warrant prompt medical evaluation
These agents should not be used if fever, bloody stools, or severe abdominal pain are present, as these symptoms may indicate a more serious condition requiring medical evaluation
US$ 27.69
US$ 28.44
US$ 29.28
US$ 28.76
US$ 28.49
US$ 29.03
